The short version of circular dichroism fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-31 and is reviewed periodically as new material appears.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual agonist profile distinguishes it from earlier incretin-based compounds that act on a single receptor. The molecule was engineered from the native GIP sequence and carries several non-natural residues that slow enzymatic breakdown. Researchers designed it to combine the insulinotropic effects of GIP signaling with the appetite and gastric-emptying effects associated with GLP-1 activation.
| Property | Value | Notes |
|---|---|---|
| Primary purity method | Reversed-phase HPLC | Ultraviolet detection near 214 nm |
| Identity confirmation | Intact mass by LC-MS | Compared with theoretical average mass |
| Sequence verification | Enzymatic peptide mapping | Tandem mass spectrometry of fragments |
| Common degradation route | Deamidation and oxidation | Rate increases with pH and temperature |
| Reference material | Lyophilized peptide standard | Stored desiccated below -20 °C |
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
== History == The physical principles of ion traps were first explored by F. M. Penning, who observed that electrons released by the cathode of an ionization vacuum gauge follow a long cycloidal path to the anode in the presence of a sufficiently strong magnetic field. Later Wolfgang Paul developed a method to trap ions without magnetic fields that was based on his work with quadrupole mass spectrometers. Ion traps were used in television receivers prior to the introduction of aluminized CRT faces around 1958, to protect the phosphor screen from ions. The ion trap must be delicately adjusted for maximum brightness.
Meanwhile, Khrushchev broadened Moscow's policy to establish ties with India and other key neutral states. Independence movements in the Third World transformed the post-war order into a more pluralistic world of decolonized African and Middle Eastern nations and of rising nationalism in Asia and Latin America.
In rural Vermont, 48% of respondents in treatment reported they had missed an appointment due to travel challenges. Because of issues like these, it is estimated that, nationwide, only 10% of individuals who would be eligible to receive MAT actually receive the treatment. The price of opioid treatment may vary due to different factors, but the cost of treatment can range from $6,000 to $15,000 a year. Based on the research, most addicts come from lagging economic environment which multiple addicts do not have the support or funding to complete alternative medication for the addictions.
===== Penis ===== In 2020, researchers developed a method for tissue repair of male genitals through the use of a bioink they designed. This bioink would include stem cells along with the ink itself to increase its compatibility with the body and its ability to heal. A hydrogel scaffold was printed using a 3D print-ultraviolet photo crosslinking strategy, which is similar in concept to an SLA printer. Their design was able to successfully be integrated the corpus cavernosum of a rabbit's penis. This printed structure was able to return functionality to the organ and increase its fertility. While not tested or created using human cells, further efforts are being conducted to improve this field.
Sources: en.wikipedia.org
In the early modern period, successor states to the Adal Sultanate and Ajuran Sultanate began to flourish in Somalia. These included the Hiraab Imamate, the Isaaq Sultanate led by the Guled dynasty, the Habr Yunis Sultanate led by the Ainanshe dynasty, the Sultanate of the Geledi (Gobroon dynasty), the Majeerteen Sultanate (Migiurtinia), and the Sultanate of Hobyo (Obbia). They continued the tradition of castle-building and seaborne trade established by previous Somali empires. Sultan Yusuf Mahamud Ibrahim, the third Sultan of the House of Gobroon, started the golden age of the Gobroon Dynasty. His army came out victorious during the Bardheere Jihad, which restored stability in the region and revitalised the East African ivory trade. He also had cordial relations and received gifts from the rulers of neighbouring and distant kingdoms such as the Omani, Witu and Yemeni Sultans. Sultan Ibrahim's son Ahmed Yusuf succeeded him as one of the most important figures in 19th-century East Africa, receiving tribute from Omani governors and creating alliances with important Muslim families on the East African coast.
The continental policy of England [after 1525] was fixed. It was to be pacific, mediating European affairs, favorable to a balance which should prevent any power from having a hegemony on the continent or controlling the Channel coasts. The naval security of England and the balance of power in Europe were the two great political principles which appeared in the reign of Henry VIII and which, pursued unwaveringly, were to create the greatness of England. In 1579, the first English translation of Francesco Guicciardini's Storia d'Italia ("History of Italy") popularised the Italian balance of power theory in England. This translation was dedicated to Elizabeth I of England and claimed that "God has put into your hand the balance of power and justice, to poise and counterpoise at your will the actions and counsels of all the Christian kings of your time". Thomas Carlyle referred to statesmen "in shadow-hunting, shadow-hunted hour ... looking with intense anxiety into a certain spectral something they call the Balance of Power." Statesman Richard Cobden labeled the balance of power "a chimera" due to its unclear meaning: "It is not a fallacy, a mistake, an imposture—it is an undescribed, indescribable, incomprehensible nothing." The only point on which writers on the balance of power agree "is in the fundamental delusion that such a system was ever acceded to by the nations of Europe." They imply long, uninterrupted, peaceful and prosperous co-existence.
== Role in cancer biology == The Src family of kinases is commonly associated with its role in "invasion and tumor progression, epithelial-to-mesenchymal transition, angiogenesis, and development of metastasis," all hallmarks of cancer progression. Fyn's normal function in cellular growth and proliferation has the potential to be exploited in the progression and metastasis of cancer cells. Overexpression of Fyn has been found to drive morphologic transformation in normal cells and increase "anchorage-independent growth and prominent morphologic changes." Fyn overexpression has been studied in relation to the following cancers: prostate cancer, glioblastoma multiform, squamous cell carcinoma of the head and neck, pancreatic cancer, chronic melogenic leukemia, and melanoma. This overexpression triggers a promotion of "anti-apoptotic activity of Akt" in prostate cancer, meaning that these cells have gained the ability to avoid the normal cell death pathways (a common hallmark of cancer). Additionally, in glioblastoma multiform, Src and Fyn have been found to be "effectors of oncogenic EGFR signaling" which has led to tumor invasion and cancer cell survival. Fyn's normal role in cell migration and adhesion enables it to utilize the normal cell biology of integrin and FAK for cancer growth. Normal integrin is a cell surface receptor that interacts with the extracellular matrix to send signals influencing cell shape and motility. Normal FAK is a tyrosine kinase that gets recruited to focal adhesion sites and plays a key role in directed cell movement.
We found ourselves rushing things, cutting things, making quality sacrifices we did not want to make." Montero said then they decided to re-evaluate the state of the project, set higher bars for the quality of work they wanted to produce, and started to back through what they had already done to improve upon that, at which point they were not sure when the project would be completed. The first standalone version of Black Mesa was released as a free download on September 14, 2012. This contained remakes of all Half-Life's chapters except the final chapter set on the alien world Xen, which the team intended to rework for inclusion in a future release, as Xen in the original Half-Life was often considered its weakest part. The development team estimated that the initial release of Black Mesa gave players eight to ten hours of content to complete. Black Mesa's initial release coincided with the launch of Valve's Steam Greenlight program which allowed users to vote for games to be put onto the Steam storefront. Black Mesa became one of the first ten titles to be voted on by fans and approved by Valve to be included on Steam through Greenlight.
=== Pharmacoperones === Current research is looking into pharmacoperones, or chemical chaparones that promote the shuttling of mature Gonadotropin-releasing hormone receptor (GNRHR) protein to the cell surface, leading to a functional protein. Gonadotropin-releasing hormone receptor function has been shown to be deleteriously effected by point mutations in its gene. Some of these mutations, when expressed, cause the receptor to remain in the cytosol. An approach to rescue receptor function utilizes pharmacoperones or molecular chaperones, which are typically small molecules that rescue misfolded proteins to the cell surface. These interact with the receptor to restore cognate receptor function devoid of antagonist or agonist activity. This approach, when effective, should increase therapeutic reach. Pharmacoperones have been identified that restore function of Gonadotropin-releasing hormone receptor.
Sources: en.wikipedia.org
Peptide mapping with tandem mass spectrometry is the standard approach. The peptide is digested with an enzyme such as trypsin, and the resulting fragments are matched against the expected sequence.
Higher pH and elevated temperature both increase deamidation rates. Holding solutions at low temperature and near-neutral to slightly acidic pH reduces the extent of the reaction.
Removing water slows hydrolysis and aggregation. The dry powder tolerates longer storage intervals than a solution kept at the same temperature.
It binds and activates both the GIP and GLP-1 receptors, making it a dual incretin receptor agonist. Single-receptor GLP-1 agonists act on one target only. The dual profile is the defining pharmacological feature of the molecule.